BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 25633981)

  • 21. Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.
    Sharp JA; Mailer SL; Thomson PC; Lefèvre C; Nicholas KR
    Mol Cancer; 2008 Jan; 7():1. PubMed ID: 18179684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EO771, the first luminal B mammary cancer cell line from C57BL/6 mice.
    Le Naour A; Koffi Y; Diab M; Le Guennec D; Rougé S; Aldekwer S; Goncalves-Mendes N; Talvas J; Farges MC; Caldefie-Chezet F; Vasson MP; Rossary A
    Cancer Cell Int; 2020; 20():328. PubMed ID: 32699527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor.
    Efeyan A; Fabris V; Merani S; Lanari C; Molinolo AA
    Breast Cancer Res Treat; 2004 Feb; 83(3):233-44. PubMed ID: 14758093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.
    Eckhardt BL; Parker BS; van Laar RK; Restall CM; Natoli AL; Tavaria MD; Stanley KL; Sloan EK; Moseley JM; Anderson RL
    Mol Cancer Res; 2005 Jan; 3(1):1-13. PubMed ID: 15671244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing of TLR4 increases tumor progression and lung metastasis in a murine model of breast cancer.
    Ahmed A; Wang JH; Redmond HP
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S389-96. PubMed ID: 22890596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target-Specific Imaging of Cathepsin and S100A8/A9 Reflects Specific Features of Malignancy and Enables Estimation of Tumor Malignancy.
    Helfen A; Große Hokamp N; Geyer C; Heindel W; Bremer C; Vogl T; Höltke C; Masthoff M; Barczyk-Kahlert K; Roth J; Wildgruber M; Eisenblaetter M
    Mol Imaging Biol; 2020 Feb; 22(1):66-72. PubMed ID: 31098983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
    Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
    J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.
    Smith YE; Toomey S; Napoletano S; Kirwan G; Schadow C; Chubb AJ; Mikkelsen JH; Oxvig C; Harmey JH
    BMC Cancer; 2018 Oct; 18(1):1016. PubMed ID: 30348128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer.
    Sun B; Zhang S; Zhang D; Li Y; Zhao X; Luo Y; Guo Y
    Clin Cancer Res; 2008 Nov; 14(21):7050-9. PubMed ID: 18981002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer.
    Steenbrugge J; Vander Elst N; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Dirix L; Van Laere S; Meyer E
    Front Immunol; 2019; 10():2928. PubMed ID: 31921184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of GTPase activating protein Git2 on metastasis in breast cancer].
    Zhou W; Cao MG; Xu J; Fang ZY; Wang XY; Guo ZP; Li SS; Zhou ZH
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):492-8. PubMed ID: 27531261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.
    O'Regan RM; Osipo C; Ariazi E; Lee ES; Meeke K; Morris C; Bertucci A; Sarker MA; Grigg R; Jordan VC
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2255-63. PubMed ID: 16609042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring IGF-1, ER-α and EGFR expression can predict tamoxifen-resistance in ER-positive breast cancer.
    Chong K; Subramanian A; Sharma A; Mokbel K
    Anticancer Res; 2011 Jan; 31(1):23-32. PubMed ID: 21273576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.
    Morris JS; Nixon C; Bruck A; Nasir L; Morgan IM; Philbey AW
    Vet J; 2008 Feb; 175(2):218-26. PubMed ID: 17336111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
    Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
    Oates AJ; Barraclough R; Rudland PS
    Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular phenotype in mammary tumours of queens: correlation between primary tumour and lymph node metastasis.
    Brunetti B; Asproni P; Beha G; Muscatello LV; Millanta F; Poli A; Benazzi C; Sarli G
    J Comp Pathol; 2013 Feb; 148(2-3):206-13. PubMed ID: 22819018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the MDSC proteome associated with metastatic murine mammary tumors using label-free mass spectrometry and shotgun proteomics.
    Boutté AM; McDonald WH; Shyr Y; Yang L; Lin PC
    PLoS One; 2011; 6(8):e22446. PubMed ID: 21853032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.